This session explores the use of anti-obesity medications through complex case-based scenarios, providing a hands-on approach to understanding their application in real-world situations.
|
This presentation explores emerging investigational therapies designed to combat obesity.
|
Rising obesity rates are driving an epidemic of obesity-related OSA while access to care from a sleep specialist is limited.
|
The rise in the use of glucagon-like peptide 1 receptor agonists (GLP-1RA) for weight loss has generated significant interest due to their efficacy in reducing body weight.
|
Obesity Medicine 2023 - Spring Obesity Summit
|
Pages
- « first
- ‹ previous
- 1
- 2
- 3
- 4